187 related articles for article (PubMed ID: 18160213)
1. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line.
Persson F; Olofsson A; Sjögren H; Chebbo N; Nilsson B; Stenman G; Aman P
Cancer Lett; 2008 Feb; 260(1-2):37-47. PubMed ID: 18160213
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
4. Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH.
Meléndez B; Martínez-Delgado B; Cuadros M; Fernández V; Díaz-Uriarte R; Benítez J
Mol Cancer; 2005 Jan; 4(1):5. PubMed ID: 15656903
[TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
Heidenblad M; Hallor KH; Staaf J; Jönsson G; Borg A; Höglund M; Mertens F; Mandahl N
Oncogene; 2006 Nov; 25(53):7106-16. PubMed ID: 16732325
[TBL] [Abstract][Full Text] [Related]
8. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.
Weng WH; Wejde J; Ahlén J; Pang ST; Lui WO; Larsson C
Cancer Genet Cytogenet; 2004 Apr; 150(1):27-32. PubMed ID: 15041220
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
10. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications.
Chibon F; Mariani O; Derré J; Mairal A; Coindre JM; Guillou L; Sastre X; Pédeutour F; Aurias A
Genes Chromosomes Cancer; 2004 May; 40(1):32-7. PubMed ID: 15034865
[TBL] [Abstract][Full Text] [Related]
11. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
12. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
[TBL] [Abstract][Full Text] [Related]
13. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
14. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.
Pedeutour F; Maire G; Pierron A; Thomas DM; Garsed DW; Bianchini L; Duranton-Tanneur V; Cortes-Maurel A; Italiano A; Squire JA; Coindre JM
Virchows Arch; 2012 Jul; 461(1):67-78. PubMed ID: 22678079
[TBL] [Abstract][Full Text] [Related]
15. Distinct MDM2 and P14ARF expression and centrosome amplification in well-differentiated liposarcomas.
Perucca-Lostanlen D; Rostagno P; Grosgeorge J; Marcié S; Gaudray P; Turc-Carel C
Genes Chromosomes Cancer; 2004 Feb; 39(2):99-109. PubMed ID: 14695989
[TBL] [Abstract][Full Text] [Related]
16. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
18. Pairwise comparison of genomic imbalances between primary and recurrent well differentiated liposarcomas.
Micci F; Bjerkehagen B; Heim S
Cancer Genet Cytogenet; 2007 Oct; 178(2):163-7. PubMed ID: 17954275
[TBL] [Abstract][Full Text] [Related]
19. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas.
Pérot G; Derré J; Coindre JM; Tirode F; Lucchesi C; Mariani O; Gibault L; Guillou L; Terrier P; Aurias A
Cancer Res; 2009 Mar; 69(6):2269-78. PubMed ID: 19276386
[TBL] [Abstract][Full Text] [Related]
20. Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas.
Italiano A; Chambonniere ML; Attias R; Chibon F; Coindre JM; Pedeutour F
Cancer Genet Cytogenet; 2008 Jul; 184(2):99-104. PubMed ID: 18617058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
